Welcome to CDC stacks | Risk of Adverse Health Outcomes with Increasing Duration and Regularity of Opioid Therapy - 80102 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Risk of Adverse Health Outcomes with Increasing Duration and Regularity of Opioid Therapy
  • Published Date:
    2014 May-Jun
  • Source:
    J Am Board Fam Med. 27(3):329-338
  • Language:
    English
Filetype[PDF-393.85 KB]


Details:
  • Pubmed ID:
    24808111
  • Pubmed Central ID:
    PMC6660001
  • Description:
    Purpose:

    The purpose of this study was to examine trends in frequency and daily dosage of opioid use and related adverse health outcomes in a commercially insured population.

    Methods:

    We examined medical claims from the Truven Health MarketScan commercial claims data-base for 789,457 continuously enrolled patients ages 18 to 64 years to whom opioids were dispensed during the first half of 2008. We tracked them every 6 months until either opioid use was discontinued or the end of 2010. We compared outcomes among all opioid users with those for patients who used opioids with only limited interruptions during the index period, referred to as “daily users.” We contrasted the experience of daily users, other users, and nonusers for various outcomes.

    Results:

    Of all claimants, 10.7% had at least one opioid prescription during the first 6 months of 2008. Of these, 39.9% continued through a second 6-month period, and 18.0% continued through the end of 2010. Only 9.0% of all users qualified as daily users, but 87.1% of them continued some use of opioids through the end of 2010. Only 43.8% of all users who continued use through 2010 initially qualified as daily users. Among all users who continued use through 2010, days of use and daily dosage increased with duration of use. Among daily users, only dosage increased, rising from 101 to 114 morphine milligram equivalents/day over the 3 years. The prevalence of benzodiazepine use was greater for daily than all users, exceeding 40% among daily users who continued opioid use for 3 years. Drug abuse and overdose rates increased with longer use. Daily users accounted for 25.0%, other users for 43.6%, and nonusers for 31.4% of opioid analgesic overdoses.

    Conclusions:

    Adverse health outcomes can increase with accumulating opioid use and increasing dosage. Existing guidelines developed by specialty societies for managing patients using opioids daily or nearly daily do not address the larger number of patients who use opioids intermittently over periods of years. Practitioners should consider applying such guidelines to patients who use opioids less frequently. (J Am Board Fam Med 2014;27:329–338.)

  • Document Type:
  • Collection(s):
  • Main Document Checksum:
No Related Documents.
You May Also Like: